Cigna Group (CI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 100B 200B 300B Q3 '21: 170.1B Q4 '21: 174.1B Q1 '22: 177.1B Q2 '22: 179.5B Q3 '22: 180.4B Q4 '22: 180.5B Q1 '23: 183B Q2 '23: 186.1B Q3 '23: 189.9B Q4 '23: 195.3B Q1 '24: 206B Q2 '24: 217.9B Q3 '24: 232.6B Q4 '24: 247.1B Q1 '25: 255.4B Q2 '25: 262B Q3 '25: 268.1B Q4 '25: 274.9B Q1 '26: 277.9B Q2 '26: 282.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 3.5B 7B 10.5B Q3 '21: 7.7B Q4 '21: 7.9B Q1 '22: 8.2B Q2 '22: 8.4B Q3 '22: 8.2B Q4 '22: 8.4B Q1 '23: 8.3B Q2 '23: 8.1B Q3 '23: 8.2B Q4 '23: 8.5B Q1 '24: 8.8B Q2 '24: 9B Q3 '24: 9.3B Q4 '24: 9.4B Q1 '25: 9.1B Q2 '25: 9B Q3 '25: 9B Q4 '25: 9.2B Q1 '26: 9.6B Q2 '26: 10B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 3B 6B 9B Q3 '21: 8.4B Q4 '21: 5.4B Q1 '22: 5.5B Q2 '22: 5.6B Q3 '22: 6.7B Q4 '22: 6.8B Q1 '23: 6.9B Q2 '23: 6.8B Q3 '23: 5.5B Q4 '23: 5.4B Q1 '24: 3.9B Q2 '24: 4B Q3 '24: 3.3B Q4 '24: 3.8B Q1 '25: 5.3B Q2 '25: 5.2B Q3 '25: 6.4B Q4 '25: 6.1B Q1 '26: 6.4B Q2 '26: 6.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 80B 160B 240B Q3 '21: 113.4B Q4 '21: 117.6B Q1 '22: 120.1B Q2 '22: 122.3B Q3 '22: 124B Q4 '22: 124.8B Q1 '23: 126.5B Q2 '23: 128.8B Q3 '23: 130.6B Q4 '23: 133.8B Q1 '24: 143.8B Q2 '24: 154.8B Q3 '24: 168.7B Q4 '24: 182.5B Q1 '25: 189.5B Q2 '25: 198.3B Q3 '25: 206.2B Q4 '25: 215B Q1 '26: 220.7B Q2 '26: 224.1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 5B 10B 15B Q3 '21: 7.2B Q4 '21: 7.2B Q1 '22: 8.1B Q2 '22: 9.7B Q3 '22: 10.8B Q4 '22: 8.7B Q1 '23: 11.7B Q2 '23: 12.9B Q3 '23: 12.4B Q4 '23: 11.8B Q1 '24: 11.6B Q2 '24: 9.4B Q3 '24: 6.6B Q4 '24: 10.4B Q1 '25: 7.4B Q2 '25: 5.3B Q3 '25: 8.7B Q4 '25: 9.6B Q1 '26: 8.8B Q2 '26: 10.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 3B 6B 9B Q4 '18: 3.2B Q1 '19: 4.3B Q2 '19: 4.2B Q3 '19: 5.9B Q4 '19: 8.4B Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 374.6M Q2 '20: 370.7M Q3 '20: 367.2M Q1 '21: 352M Q2 '21: 344.9M Q3 '21: 337.6M Q1 '22: 321.3M Q2 '22: 318.3M Q3 '22: 307.5M Q1 '23: 299M Q2 '23: 296.9M Q3 '23: 297.1M Q1 '24: 286.5M Q2 '24: 284.1M Q3 '24: 281.4M Q1 '25: 273M Q2 '25: 268.2M Q3 '25: 267.5M Q1 '26: 264M Q2 '26: 264M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 9.00 18.00 27.00 Q3 '21: 23.65 Q4 '21: 15.78 Q1 '22: 16.21 Q2 '22: 16.85 Q3 '22: 21.02 Q4 '22: 21.54 Q1 '23: 22.05 Q2 '23: 22.08 Q3 '23: 17.85 Q4 '23: 17.40 Q1 '24: 12.19 Q2 '24: 12.72 Q3 '24: 10.61 Q4 '24: 12.18 Q1 '25: 18.00 Q2 '25: 18.26 Q3 '25: 22.61 Q4 '25: 22.20 Q1 '26: 23.61 Q2 '26: 24.19 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.